PerpEquities

Biogen Inc. (BIIB) balance sheet

NASDAQ · Healthcare · Drug Manufacturers - General · 7,500 employees · CEO Christopher A. Viehbacher

Price
$253.62 +1.59%
Market cap
$37.5B
Enterprise value
$44B
Last report
Q3 '26 filed 2026-10-28
Next report
2027-02-05 EPS est. $2.85

At the end of Q3 '26 Biogen Inc. (BIIB) held $1.3B in cash and short-term investments against $7.8B of debt incl. leases. Total assets $32.1B, total liabilities $13.1B, shareholders' equity $18.9B.

Balance sheet

Balance sheetTrendQ4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Assets
Cash & equivalents$1.05B$1.07B$1.91B$1.7B$2.38B$2.6B$2.76B$3.86B$3.01B$3.38B$1.29B$1.3B
Short-term investments$0$0$0$0$0$0$0$97.6M$807M$900M$0$0
Receivables$2.1B$2B$2.08B$1.99B$1.87B$2B$2.08B$1.85B$1.87B$1.79B$1.89B$1.88B
Inventory$2.53B$2.52B$2.51B$2.47B$2.46B$2.27B$2.27B$2.21B$2.17B$1.95B$2.38B$2.22B
Other current assets$1.18B$1.17B$615M$674M$753M$757M$851M$917M$1.12B$1.17B$1.75B$2.17B
Current assets$6.86B$6.76B$7.11B$6.83B$7.46B$7.63B$7.97B$8.94B$8.97B$9.19B$7.31B$7.58B
Property, plant & equipment (net)$3.73B$3.7B$3.64B$3.59B$3.54B$3.48B$3.43B$3.41B$3.32B$3.27B$3.24B$3.14B
Long-term investments$461M$382M$354M$353M$227M$186M$224M$167M$751M$466M$832M$660M
Goodwill$6.22B$6.23B$6.23B$6.49B$6.48B$6.48B$6.49B$6.49B$6.49B$6.49B$6.99B$6.99B
Intangible assets$8.36B$8.28B$8.23B$9.81B$9.69B$9.58B$9.47B$9.33B$9.18B$9.05B$13.5B$13.4B
Deferred tax assets$929M$898M$915M$969M$324M$308M$331M$312M$293M$238M$202M$294M
Other non-current assets$284M$316M$327M$278M$334M$373M$414M$563M$432M$778M$0$0
Non-current assets$20B$19.8B$19.7B$21.5B$20.6B$20.4B$20.4B$20.3B$20.5B$20.3B$24.8B$24.5B
Total assets$26.8B$26.6B$26.8B$28.3B$28B$28B$28.3B$29.2B$29.4B$29.5B$32.1B$32.1B
Liabilities
Accounts payable$403M$387M$355M$423M$424M$392M$408M$413M$432M$359M$404M$430M
Accrued expenses$2.29B$1.48B$1.55B$1.83B$2.43B$2.34B$2.28B$2.37B$0$2.35B$2.24B$2.05B
Short-term debt$150M$250M$0$1.75B$1.75B$1.75B$0$0$80.4M$0$800M$400M
Taxes payable$257M$231M$282M$499M$548M$626M$115M$103M$115M$93.6M$86.9M$0
Other current liabilities$335M$879M$918M$926M$376M$192M$385M$400M$2.72B$193M$391M$1.01B
Current liabilities$3.43B$3.22B$3.11B$5.43B$5.53B$5.3B$3.18B$3.29B$3.35B$3B$3.92B$3.9B
Long-term debt$6.79B$6.29B$6.29B$4.55B$4.55B$4.55B$6.28B$6.29B$6.58B$6.29B$7.29B$7.29B
Lease obligations (non-current)$400M$407M$368M$357M$335M$323M$311M$305M$290M$273M$265M$109M
Deferred tax liabilities$642M$658M$591M$882M$191M$133M$118M$358M$508M$484M$946M$1.16B
Other non-current liabilities$781M$777M$557M$744M$732M$752M$800M$762M$458M$787M$821M$668M
Non-current liabilities$8.61B$8.13B$7.81B$6.53B$5.8B$5.76B$7.51B$7.71B$7.83B$7.83B$9.32B$9.23B
Total liabilities$12B$11.4B$10.9B$12B$11.3B$11.1B$10.7B$11B$11.2B$10.8B$13.2B$13.1B
Equity
Common stock & paid-in capital$100K$100K$100K$100K$100K$100K$100K$100K$100K$100K$100K$100K
Retained earnings$17.6B$18B$18.6B$19B$19.3B$19.5B$20.1B$20.6B$20.6B$20.9B$21B$20.9B
Accumulated other comprehensive income-$154M-$161M-$146M-$146M-$136M-$175M-$238M-$215M-$182M-$140M-$128M-$120M
Shareholders' equity$14.8B$15.2B$15.9B$16.4B$16.7B$17B$17.6B$18.2B$18.3B$18.7B$18.8B$18.9B
Debt
Total debt (incl. leases)$7.34B$6.95B$6.66B$6.65B$6.63B$6.62B$6.59B$6.59B$6.95B$6.56B$8.36B$7.8B
Net debt (debt - cash)$6.29B$5.87B$4.75B$4.95B$4.26B$4.02B$3.84B$2.73B$3.94B$3.18B$7.07B$6.5B

Standardised by Financial Modeling Prep from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.

Cash, investments and debt

quarter ends

The other statements

Sources

Statements, segment revenue, metrics, estimates: Financial Modeling Prep. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-09-30, 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30

Data as of 2026-11-02